1 |
Geometric and wall pressure characterization of patient abdominal aortic aneurysmAslani, Elham 07 December 2005 (has links)
Graduation date: 2006
|
2 |
Verpleegstandaarde vir 'n pasiënt met 'n abdominale aorta aneurisme na 'n endovaskulêre stent herstel22 November 2010 (has links)
M.Cur. / The natural progress of an abdominal aortic aneurysm is enlargement and rupture. The incidence of abdominal aortic aneurysms has increased in the past 30 years and up to 50% of the patients with untreated aneurysms will die due to rupture within 5 years. Open surgery is effective in the prevention of rupture and can be performed with a mortality of 2 -5% in most cases. However, patients with aneurysms are generally older and have associated medical co-morbidities, which increase the risk in surgical intervention. In view of these associated risks with open surgery for abdominal aorta aneurysm repair, a less invasive option such as endoluminal stent-grafts, are often preferred. This new, less invasive technique with Parodi as pioneer has several advantages for patients, the greatest being the reduction in peri-operative risks of aneurysm repair. As in all new procedures, this new intervention sets specific requirements for quality peri-operative nursing. Within the legal-ethical framework of nursing there is no room for random nursing, and we as nurses must turn to protocols and standards applicable to quality nursing, and in effect the quality assurance process. Quality nursing care delivery to the patient remains the ideal of each nurse. The endovascular repair of abdominal aortic aneurysms, although less invasive, is still associated with major morbidity and mortality. The potential for complications is a reality. Complications are mainly systemic and/or procedure related. The reality of these complications affects the quality of nursing. Finally, the need to accommodate this problem requires that protocol/standards are established for the nursing of the patient with an endoluminal repair of an abdominal aortic aneurysm by means of an endovascular stent-graft. The following question can be asked in view of the above arguments and problem statement: How must these patients be nursed peri-operatively to ensure quality nursing care? The aim of this study is to compile protocol/standards for quality nursing of patients with an erldovascular stent-graft repair of an abdominal aortic aneurysm in a Coronary Intensive Care Unit in a private hospital in Cape Town.
|
3 |
Economic evaluation of screening for abdominal aortic aneurysm in elderly men in Hong KongAi, Yaping, 艾亚萍 January 2013 (has links)
Background: Abdominal aortic aneurysm (AAA) is a degenerative disease prevailing in men aged 65 years and above. Most AAA patients are asymptomatic until the disease develops to a very severe stage. Systematic screening could detect AAA in an early stage and early treatment is therefore provided to prevent AAA rupture and reduce AAA-related death. Ultrasonography is a recommended tool for AAA screening, which has been widely used in several western countries. Hong Kong currently has not introduced this screening programme yet. The present study attempts to investigate the health related quality of life (HRQOLO) of AAA patients in Hong Kong and then examine whether a systematic screening in elderly men in Hong Kong is cost effective compare with current practice (Non-screening strategy)
Methods: Firstly, a questionnaire based study was conducted in a local university-affiliated vascular tertiary referral center targeting on AAA patients. Quality of life data was collected by a face-to-face interview using the Medical Outcomes Study Short-Form-36 Health Survey (SF-36). A controlled group was obtained from a large local population study matched by gender and age to the AAA group. The SF-36 scores were compared between the two groups; a stepwise multivariate regression analysis was conducted to show the association between the disease and the SF-36 scores.
Secondly, a cost effectiveness analysis based on a Markov model was conducted to compare the screening strategy against non-screening practice. Incremental cost effectiveness ratios (ICER) was adopted as the rule of decision making. One-way sensitivity analysis and probabilistic analysis were performed to explore the uncertainty around the parameters.
Results: 172 out of 252 patients participated the interview, among which 80% were aged 65 years or above, and 85% were males. Around 80% patients were detected incidentally. Comparing with the age and gender matched control group, AAA patients had an impaired HRQOL The disease adversely affected mental health summary of AAA patients.
Under the discount rate of 3% on costs and effectiveness, the incremental costs of systematic screening against non-screening is HK$3,710.3; and the incremental life year gained and quality adjusted life year (QALY) gained are 0.024 and 0.014, respectively. The ICER is HK$ 151,070.1 per life year gained and HK$ 268,897.6 per QALY gained, which is cost effective under the threshold of one GDP per capita (HK$285,403) for one QALY gained.
Conclusion: The economic evaluation based on the Markov model indicated systematic screening for AAA among elderly men in Hong Kong is cost effective. Government in Hong Kong should consider introducing the screening programme when resource is available. / published_or_final_version / Public Health / Master / Master of Philosophy
|
4 |
The genetics of abdominal aortic aneurysmsRossaak, Jeremy Ian, n/a January 2004 (has links)
Abdominal Aortic Aneurysms (AAA) are amongst the top ten most common cause of death in those over 55 years of age. The disease is usually asymptomatic, often being diagnosed incidentally. Once diagnosed, elective repair of an AAA results in excellent long-term survival with a 3-5% operative mortality. However, up to one half of patients present with ruptured aneurysms, a complication that carries an 80% mortality in the community, and of those reaching hospital, a 50% mortality. Clearly early diagnosis and treatment results in improved survival. Screening for AAA, with ultrasound, would detect aneurysms early, prior to rupture. However, debate continues over the cost effectiveness of population based screening programmes. The identification of a sub-population at a higher risk of developing AAA would increase the yield of a screening prograrmne. A number of populations have been examined, none of which have received international acceptance. About 20% of patients with an AAA have a family history of an aneurysm. The disease is also considered to be a disease of Caucasians, both facts suggesting a strong genetic component to the disease. Perhaps a genetically identified sub-population at a high risk of developing an AAA would prove to be an ideal population for screening. This thesis examines the incidence of aneurysms and the family histories of patients with AAA in the Otago region of New Zealand. Almost twenty percent of the population has a family history of AAA. DNA was collected from each of these patients for genetic analysis. The population was divided into familial AAA and non-familial AAA for the purpose of genetic analysis and compared to a control population. AAA is believed to be a disease of Caucasians; a non-Caucasian population with a low incidence of AAA may prove to be a good control population for genetic studies. A literature review demonstrated a higher incidence of AAA in Caucasians than other ethnic groups and within Caucasians a higher incidence in patients of Northern European origin. The incidence was low in Asian communities, even in studies involving of migrant Asian populations. The New Zealand Maori are believed to have originated from South East Asia, therefore could be expected to have a low incidence of AAA and would make an ideal control population for genetic studies. A pilot study was undertaken to examine the incidence of AAA in the New Zealand Maori. The age standardised incidence of AAA proved to be at least equal in Maori to non-Maori, with a more aggressive form of the disease in Maori, manifesting with a younger age at presentation and a higher incidence of ruptured aneurysms at diagnosis. It is well known that at the time of surgery, an AAA
|
5 |
Endovascular repair of abdominal aortic aneurysms aspects on a novel technique /Malina, Martin. January 1998 (has links)
Thesis (doctoral)--Lund University, 1998. / Added t.p. with thesis statement inserted.
|
6 |
Endovascular repair of abdominal aortic aneurysms aspects on a novel technique /Malina, Martin. January 1998 (has links)
Thesis (doctoral)--Lund University, 1998. / Added t.p. with thesis statement inserted.
|
7 |
The genetics of abdominal aortic aneurysmsRossaak, Jeremy Ian, n/a January 2004 (has links)
Abdominal Aortic Aneurysms (AAA) are amongst the top ten most common cause of death in those over 55 years of age. The disease is usually asymptomatic, often being diagnosed incidentally. Once diagnosed, elective repair of an AAA results in excellent long-term survival with a 3-5% operative mortality. However, up to one half of patients present with ruptured aneurysms, a complication that carries an 80% mortality in the community, and of those reaching hospital, a 50% mortality. Clearly early diagnosis and treatment results in improved survival.
Screening for AAA, with ultrasound, would detect aneurysms early, prior to rupture. However, debate continues over the cost effectiveness of population based screening programmes. The identification of a sub-population at a higher risk of developing AAA would increase the yield of a screening prograrmne. A number of populations have been examined, none of which have received international acceptance.
About 20% of patients with an AAA have a family history of an aneurysm. The disease is also considered to be a disease of Caucasians, both facts suggesting a strong genetic component to the disease. Perhaps a genetically identified sub-population at a high risk of developing an AAA would prove to be an ideal population for screening.
This thesis examines the incidence of aneurysms and the family histories of patients with AAA in the Otago region of New Zealand. Almost twenty percent of the population has a family history of AAA. DNA was collected from each of these patients for genetic analysis. The population was divided into familial AAA and non-familial AAA for the purpose of genetic analysis and compared to a control population.
AAA is believed to be a disease of Caucasians; a non-Caucasian population with a low incidence of AAA may prove to be a good control population for genetic studies. A literature review demonstrated a higher incidence of AAA in Caucasians than other ethnic groups and within Caucasians a higher incidence in patients of Northern European origin. The incidence was low in Asian communities, even in studies involving of migrant Asian populations. The New Zealand Maori are believed to have originated from South East Asia, therefore could be expected to have a low incidence of AAA and would make an ideal control population for genetic studies. A pilot study was undertaken to examine the incidence of AAA in the New Zealand Maori. The age standardised incidence of AAA proved to be at least equal in Maori to non-Maori, with a more aggressive form of the disease in Maori, manifesting with a younger age at presentation and a higher incidence of ruptured aneurysms at diagnosis.
It is well known that at the time of surgery, an AAA is at the end stage in its life. At this time, inflammation and matrix metalloproteinases (MMP) enzymes are prevalent within the aneurysm wall and have destroyed the wall of the aorta. One of the most important genetic pathways regulating these enzymes is the plasminogen activator inhibiter 1-Tissue plasminogen activator-plasmin pathway.
Genetic analysis of this pathway demonstrated an association of the 4G5G polymorphism in the promoter of the PAl-1 gene with familial AAA. In this insertion:deletion polymorphism, the 5G variant binds an activator and repressor, resulting in reduced PAI-1 expression and ultimately increased MMP activation. This allele was associated with familial aneurysms, 47% versus 62% non-familial AAA and 61% controls (p=0.024).
A polymorphism within the tissue plasminogen activator gene was also examined and no association was found with AAA.
Another way the MMPs expression could be increased is from mutations or polymorphisms in their own genetic structure. Stromelysin 3 is itself a MMP capable of destroying the aortic wall and it has a role in activating other MMPs. A 5A6A insertion:deletion polymorphism exists in the promoter of this gene. The 5A allele variant results in increased stromelysin expression and is associated with AAA 46% versus 33% in controls p=0. 0006.
The actions of the MMPs are themselves inhibited by the tissue inhibitors of matrix metalloproteinases. The TIMP genes have been sequenced; two polymorphisms have been identified in the non-coding promoter area of the TIMP 1 gene. Further studies are necessary to examine the effect of these polymorphisms.
Inflammation has been implicated in aneurysm progression. One of the roles of the inflammatory cells found in an aneurysm is to deliver the MMP�s to the AAA. The HLA system is integral in controlling this inflammation and was therefore examined.
From this series of studies it is concluded that there is a genetic component to AAA. This thesis presents the first genetic polymorphism associated with familial AAA and explores the role of a genetic pathway in the formation of AAA.
|
8 |
Expression of sphingosine-1-phosphate receptor in abdominal aortic aneurysmQu, Zao., 瞿早. January 2011 (has links)
published_or_final_version / Surgery / Master / Master of Philosophy
|
9 |
The genetics of abdominal aortic aneurysmsRossaak, Jeremy Ian, n/a January 2004 (has links)
Abdominal Aortic Aneurysms (AAA) are amongst the top ten most common cause of death in those over 55 years of age. The disease is usually asymptomatic, often being diagnosed incidentally. Once diagnosed, elective repair of an AAA results in excellent long-term survival with a 3-5% operative mortality. However, up to one half of patients present with ruptured aneurysms, a complication that carries an 80% mortality in the community, and of those reaching hospital, a 50% mortality. Clearly early diagnosis and treatment results in improved survival.
Screening for AAA, with ultrasound, would detect aneurysms early, prior to rupture. However, debate continues over the cost effectiveness of population based screening programmes. The identification of a sub-population at a higher risk of developing AAA would increase the yield of a screening prograrmne. A number of populations have been examined, none of which have received international acceptance.
About 20% of patients with an AAA have a family history of an aneurysm. The disease is also considered to be a disease of Caucasians, both facts suggesting a strong genetic component to the disease. Perhaps a genetically identified sub-population at a high risk of developing an AAA would prove to be an ideal population for screening.
This thesis examines the incidence of aneurysms and the family histories of patients with AAA in the Otago region of New Zealand. Almost twenty percent of the population has a family history of AAA. DNA was collected from each of these patients for genetic analysis. The population was divided into familial AAA and non-familial AAA for the purpose of genetic analysis and compared to a control population.
AAA is believed to be a disease of Caucasians; a non-Caucasian population with a low incidence of AAA may prove to be a good control population for genetic studies. A literature review demonstrated a higher incidence of AAA in Caucasians than other ethnic groups and within Caucasians a higher incidence in patients of Northern European origin. The incidence was low in Asian communities, even in studies involving of migrant Asian populations. The New Zealand Maori are believed to have originated from South East Asia, therefore could be expected to have a low incidence of AAA and would make an ideal control population for genetic studies. A pilot study was undertaken to examine the incidence of AAA in the New Zealand Maori. The age standardised incidence of AAA proved to be at least equal in Maori to non-Maori, with a more aggressive form of the disease in Maori, manifesting with a younger age at presentation and a higher incidence of ruptured aneurysms at diagnosis.
It is well known that at the time of surgery, an AAA is at the end stage in its life. At this time, inflammation and matrix metalloproteinases (MMP) enzymes are prevalent within the aneurysm wall and have destroyed the wall of the aorta. One of the most important genetic pathways regulating these enzymes is the plasminogen activator inhibiter 1-Tissue plasminogen activator-plasmin pathway.
Genetic analysis of this pathway demonstrated an association of the 4G5G polymorphism in the promoter of the PAl-1 gene with familial AAA. In this insertion:deletion polymorphism, the 5G variant binds an activator and repressor, resulting in reduced PAI-1 expression and ultimately increased MMP activation. This allele was associated with familial aneurysms, 47% versus 62% non-familial AAA and 61% controls (p=0.024).
A polymorphism within the tissue plasminogen activator gene was also examined and no association was found with AAA.
Another way the MMPs expression could be increased is from mutations or polymorphisms in their own genetic structure. Stromelysin 3 is itself a MMP capable of destroying the aortic wall and it has a role in activating other MMPs. A 5A6A insertion:deletion polymorphism exists in the promoter of this gene. The 5A allele variant results in increased stromelysin expression and is associated with AAA 46% versus 33% in controls p=0. 0006.
The actions of the MMPs are themselves inhibited by the tissue inhibitors of matrix metalloproteinases. The TIMP genes have been sequenced; two polymorphisms have been identified in the non-coding promoter area of the TIMP 1 gene. Further studies are necessary to examine the effect of these polymorphisms.
Inflammation has been implicated in aneurysm progression. One of the roles of the inflammatory cells found in an aneurysm is to deliver the MMP�s to the AAA. The HLA system is integral in controlling this inflammation and was therefore examined.
From this series of studies it is concluded that there is a genetic component to AAA. This thesis presents the first genetic polymorphism associated with familial AAA and explores the role of a genetic pathway in the formation of AAA.
|
10 |
Computational and experimental investigation of steady flow fields, turbulence, and hemodynamic wall stresses in patient-specific abdominal aortic aneurysm models /Edgar, Erik S. January 1900 (has links)
Thesis (M.S.)--Oregon State University, 2009. / Printout. Includes bibliographical references (leaves 157-161). Also available on the World Wide Web.
|
Page generated in 0.0487 seconds